{
    "clinical_study": {
        "@rank": "68640", 
        "acronym": "SNS01", 
        "brief_summary": {
            "textblock": "This is a comparative, open label, parallel group, non interventional study to further\n      demonstrate the effectiveness and tolerability of Ectoin\u00ae Rhinitis Nasal Spray. In addition\n      the effectiveness and safety shall be compared to a Sinupret forte. The patient applies\n      Ectoin\u00ae Rhinitis Nasal Spray or takes Sinupret forte according to the instructions for use.\n      The observation takes place over a period of 14 days. Response to treatment is recorded at\n      day 7 and day 14 by the physician and in daily by the patient in a dairy."
        }, 
        "brief_title": "Application of Ectoin\u00ae Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis", 
        "completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "condition": "Sinusitis", 
        "condition_browse": {
            "mesh_term": [
                "Rhinitis", 
                "Sinusitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female or male individuals \u2265 18 years\n\n          -  Patients with acute Rhinosinusitis which are treated with Ectoin\u00ae Rhinitis Nasal\n             Spray or Sinupret forte during the observational period\n\n        Exclusion Criteria:\n\n          -  Contra indications according to the label"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Primary Care Clinic"
            }
        }, 
        "enrollment": {
            "#text": "66", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01684540", 
            "org_study_id": "PPL-047", 
            "secondary_id": "NIS SNS01"
        }, 
        "intervention": [
            {
                "description": "Ectoin Rhinitis Nasal Spray", 
                "intervention_name": "Medical Device, Drug-like", 
                "intervention_type": "Other"
            }, 
            {
                "intervention_name": "Sinupret forte", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "sinusitis, rhinosinusitis, ectoin, ectoine, bitop, SNS, SNS01", 
        "lastchanged_date": "September 21, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Aachen", 
                        "country": "Germany"
                    }, 
                    "name": "Dr. med. Norbert Pasch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aachen", 
                        "country": "Germany"
                    }, 
                    "name": "Dr. med. Georg Krueckels"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aachen", 
                        "country": "Germany"
                    }, 
                    "name": "Dr. med. Martin Sondermann"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Juelich", 
                        "country": "Germany"
                    }, 
                    "name": "Dr. med. Wilhelm Schuetz"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Koeln", 
                        "country": "Germany"
                    }, 
                    "name": "Taufik Shahab"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Koeln", 
                        "country": "Germany"
                    }, 
                    "name": "Peter Hinterkausen"
                }
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Non-interventional Study: Application of Ectoin\u00ae Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis", 
        "overall_official": {
            "affiliation": "Institut f\u00fcr Med. Informatik, Statistik und Epidemiologie", 
            "last_name": "Ralph M\u00f6sges, Prof.", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Changes in the symptoms of acute Rhinosinusitis assessed by the EPOS- Sinusitis-Symptom-Score", 
            "safety_issue": "No", 
            "time_frame": "day 1, day 7, day 14"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01684540"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Quality of Life questionnaire (Rhino QoL)", 
                "safety_issue": "No", 
                "time_frame": "day 1, day 7, day 14"
            }, 
            {
                "measure": "Rhinoscopy", 
                "safety_issue": "No", 
                "time_frame": "day 1, day 7, day 14"
            }, 
            {
                "measure": "Patient's and physician's judgment of efficacy", 
                "safety_issue": "No", 
                "time_frame": "day 7, day 14"
            }
        ], 
        "source": "Bitop AG", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bitop AG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2012"
    }
}